Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production
about
Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signalingCrystal structures and biochemical studies of human lysophosphatidic acid phosphatase type 6Biochemical and molecular characterization of a novel choline-specific glycerophosphodiester phosphodiesterase belonging to the nucleotide pyrophosphatase/phosphodiesterase familyProstatic acid phosphatase degrades lysophosphatidic acid in seminal plasmaAutotaxin and lysophosphatidic acid stimulate intestinal cell motility by redistribution of the actin modifying protein villin to the developing lamellipodiaBiochemical and molecular characterization of two phosphatidic acid-selective phospholipase A1s, mPA-PLA1alpha and mPA-PLA1betaStructural basis of substrate discrimination and integrin binding by autotaxinFunctional characterization of the non-catalytic ectodomains of the nucleotide pyrophosphatase/phosphodiesterase NPP1Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progressionInternational Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapyRole of Rap1B and tumor suppressor PTEN in the negative regulation of lysophosphatidic acid--induced migration by isoproterenol in glioma cellsPotential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expressionA novel acylglycerol kinase that produces lysophosphatidic acid modulates cross talk with EGFR in prostate cancer cellsReceptor and secreted targets of Wnt-1/beta-catenin signalling in mouse mammary epithelial cellsLysophosphatidic acid, LPA: a bad boy becomes goodL-histidine inhibits production of lysophosphatidic acid by the tumor-associated cytokine, autotaxinSuppression of NADPH Oxidase Activity May Slow the Expansion of Osteolytic Bone MetastasesRecent advances in targeting the autotaxin-lysophosphatidate-lipid phosphate phosphatase axis in vivoThe emerging role of FTY720 (Fingolimod) in cancer treatmentAutotaxin-LPA receptor axis in the pathogenesis of lung diseasesLipid phosphate phosphatase (LPP3) and vascular developmentRole of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapyRegulation of T cell motility in vitro and in vivo by LPA and LPA2ATX-LPA1 axis contributes to proliferation of chondrocytes by regulating fibronectin assembly leading to proper cartilage formation.Biochemical and Structural Characterization of Lysophosphatidic Acid Binding by a Humanized Monoclonal AntibodyCrystal structure of Enpp1, an extracellular glycoprotein involved in bone mineralization and insulin signalingLysophospholipid presentation by CD1d and recognition by a human Natural Killer T-cell receptorMolecular Basis of Purinergic Signal Metabolism by Ectonucleotide Pyrophosphatase/Phosphodiesterases 4 and 1 and Implications in StrokeStructural basis for specific inhibition of Autotaxin by a DNA aptamerLipid phosphate phosphatases regulate lysophosphatidic acid production and signaling in platelets: studies using chemical inhibitors of lipid phosphate phosphatase activityThe hydrolysis of lysophospholipids and nucleotides by autotaxin (NPP2) involves a single catalytic siteInhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphateDifferential gene expression profile of human tonsil high endothelial cells: implications for lymphocyte traffickingPhospholipase DSteroid binding to Autotaxin links bile salts and lysophosphatidic acid signallingPhospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizationsAutotaxin: structure-function and signalingLysophosphatidate induces chemo-resistance by releasing breast cancer cells from taxol-induced mitotic arrestAutotaxin-lysophosphatidic acid axis is a novel molecular target for lowering intraocular pressureThe heterotrimeric G protein subunits Gα(q) and Gβ(1) have lysophospholipase D activity
P2860
Q21245736-0BF72595-B9E0-46C4-B9DF-7AE0850D3CB9Q24296937-DC57349F-613A-4963-9CA4-92B54084528EQ24298713-5D8D82A8-0544-4BEA-813C-EBA0308C71C2Q24300191-C2BA9FCD-AEF4-4D2F-901D-4A605328725EQ24302009-7CAD571E-A8A9-426E-91A6-BDF152B58BF2Q24321678-3BB9362B-7D98-4051-A8D4-4457422B9AFAQ24337236-E30BB7A0-63C0-4B0F-9EEB-BE91C94D16EEQ24529870-BD8B2A0D-45D2-4954-8C0C-56E33CF6D423Q24616764-2394957D-D3E9-45DC-8D78-10F702816607Q24629255-9B0CE879-B1FD-48AA-98A9-09E8479E22C5Q24657979-63FD402D-174D-4951-AEB3-0060909A4A64Q24678496-2C9FF6BD-DF38-4404-9AC5-BF5D8FEEC154Q24678857-E9515B16-A0F4-4865-8932-AA7D5667CF4AQ24792463-2C9C2567-6FB5-4132-AB9B-8F91354A82B0Q24797056-ECB2BE50-D596-4669-B686-14D66843E7F3Q24800365-A7354492-6780-49A8-B3AD-C5314D4D6D7AQ26738400-7DDC790D-7FF0-46B9-8E2C-C81B0124F408Q26741062-8C01EFAF-BA21-4058-B3CB-0F3B87EE57C9Q26748927-42F3365E-52CE-4C64-A39F-C521F5B5BD4BQ26862679-10E19B03-E06D-4BBA-8254-88839E3B2744Q27002640-F2A99ADC-7C45-4353-BDFC-21AC002F5A98Q27015257-0920ABA7-EAC1-499D-A20B-217C85C38099Q27320538-832992FF-E99C-483B-BCAE-6482F9F4C3D4Q27329465-723061C5-B958-46EC-931A-A7E9C3C7BE0CQ27667249-B17F6E1B-8AF6-4DDE-90AA-9E683E5D567DQ27673871-EDFCDA58-6993-45BD-BBDB-018308D64ADFQ27677869-496D1707-BEB4-4265-A11F-38DB97E2725EQ27680880-B7163571-EF58-4067-8A12-6CC9EE92F178Q27704519-B490B280-FEAC-415B-96BF-9FA276E22AFFQ28156404-2B4638F1-745E-4339-A1C2-3F99ADBA0C22Q28182672-53F7E5FF-5E83-4100-A44E-3E34CADA683FQ28239967-D66FA283-12BB-4531-943D-8275626E1677Q28242325-44607C1C-A453-4A54-86A3-E1F3F945F357Q28253553-208B3B14-9BC4-46BE-BACC-CAD1C36261CDQ28274830-D20D1739-A3AE-4E32-8257-21CEB7459945Q28286551-1BA873AC-407E-4A8C-B1A5-B5AA5D134999Q28307790-A32E2504-8082-46D3-925B-80D1357965C5Q28478339-C253E4FA-1E6F-4D5A-98E5-6EEDD308E6F3Q28482420-CBD9306F-6E6C-4634-AE9A-CA8E0A8B2827Q28504918-3E30DFC7-1B26-4C5B-AB25-95BEE57195A9
P2860
Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Autotaxin has lysophospholipas ...... sophosphatidic acid production
@ast
Autotaxin has lysophospholipas ...... sophosphatidic acid production
@en
Autotaxin has lysophospholipas ...... sophosphatidic acid production
@nl
type
label
Autotaxin has lysophospholipas ...... sophosphatidic acid production
@ast
Autotaxin has lysophospholipas ...... sophosphatidic acid production
@en
Autotaxin has lysophospholipas ...... sophosphatidic acid production
@nl
prefLabel
Autotaxin has lysophospholipas ...... sophosphatidic acid production
@ast
Autotaxin has lysophospholipas ...... sophosphatidic acid production
@en
Autotaxin has lysophospholipas ...... sophosphatidic acid production
@nl
P2093
P2860
P3181
P356
P1476
Autotaxin has lysophospholipas ...... sophosphatidic acid production
@en
P2093
Akitsu Taira
Gordon B Mills
Hiroyuki Arai
Junken Aoki
Keizo Inoue
Koji Takio
Kotaro Hama
Makiko Umezu-Goto
Takao Yamori
Yasuhiro Kishi
P2860
P304
P3181
P356
10.1083/JCB.200204026
P407
P577
2002-07-22T00:00:00Z